Hospital Pharmacy welcomes contributions to this column. Articles originally published in pharmacy department newsletters are reprinted here. Material is selected because of its educational value to pharmacists or because it demonstrates the type of information of interest to newsletter readers. If you wish to have your newsletter material considered for publication in this column, mail a copy—along with a computer disk containing the document—to Neil M. Davis, Editor-in-Chief, Hospital Pharmacy, 1143 Wright Drive, Huntingdon Valley, PA 19006-2721.
Get full access to this article
View all access options for this article.
References
1.
LuzzatoL., MehtaA.Glucose-6-phosphate dehydrogenase deficiency. In: ScriverC.S., BeaudetA.L., SlyW.S., ValleD. (eds). The Metabolic Basis of Inherited Disease.6th ed.New York, NY: McGraw-Hill; 1989, 2237–65.
2.
DernR.J., BeutlerE., AlvingA.S.The hemolytic effect of primaquine: The natural course of the hemolytic anemia and the mechanism of the self-limiting character. J Lab Clin Med.1954; 44: 171–5.
WrightR.O., PerryH.E., WoolfA.D.Hemolysis after acetaminophen overdose in patients with glucose-6-phosphate dehydrogenase deficiency. Clin Toxicol.1996; 34(6): 731–4.
5.
MehtaA.B.Glucose-6-phosphate dehydrogenase deficiency. Postgrad Med J.1994; 70: 871–7.
6.
HafezM., AmarE.S., ZedanM.Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate hehy-drogenase deficiency and mild chronic hemolysis. J Pediatr.1986; 108: 558–63.
7.
JohnsonG.J., VatasseryG.T., FinkelB.High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. N Engl J Med.1983; 308: 1014–8.
